XML 26 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income (loss) $ 29,160 $ 18,410 $ (65,243)
Adjustments to reconcile net income (loss) to cash provided by operating activities:      
Loss from discontinued operations, net of tax 0 54 426
Depreciation and amortization 174,946 188,563 208,986
Long-lived asset impairment 28,127 29,142 87,435
Inventory write-downs 1,614 2,397 3,182
Amortization of deferred financing costs 6,113 6,976 6,271
Amortization of debt discount 1,410 1,325 1,245
Amortization of terminated interest rate swaps 291 552 242
Debt extinguishment loss 2,450 291 0
Interest rate swaps (131) 2,183 1,590
Stock-based compensation expense 7,388 8,461 8,969
Non-cash restructuring charges 0 997 2,158
Provision for doubtful accounts 1,677 5,144 3,637
Gain on sale of assets (5,674) (5,675) (5,999)
Loss on non-cash consideration in March 2016 Acquisition 0 0 635
Deferred income tax provision (benefit) 5,238 (59,760) (24,956)
Amortization of contract costs 14,939 0 0
Deferred revenue recognized in earnings (28,428) 0 0
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable, trade (21,028) (6,889) 32,403
Inventory 4,210 (236) 29,296
Other assets (15,249) (721) 5,547
Contract costs (32,435) 0 0
Accounts payable and other liabilities 14,964 9,616 (21,885)
Deferred revenue 36,571 730 392
Other (206) 104 (16)
Net cash provided by operating activities 225,947 201,664 274,315
Cash flows from investing activities:      
Capital expenditures (319,102) (221,693) (117,572)
Proceeds from sale of property, plant and equipment 33,927 46,954 41,892
Proceeds from insurance 252 252 0
Payment for March 2016 Acquisition 0 0 (13,779)
Net cash used in investing activities (284,923) (174,487) (89,459)
Cash flows from financing activities:      
Proceeds from borrowings of long-term debt 714,830 1,242,000 536,500
Repayments of long-term debt (605,636) (1,270,194) (675,000)
Payments for debt issuance costs (3,332) (14,855) (2,395)
(Payments for) proceeds from settlement of interest rate swaps that include financing elements 190    
(Payments for) proceeds from settlement of interest rate swaps that include financing elements   (1,785) (3,058)
Dividends to Archrock stockholders (58,288) (34,063) (34,921)
Distributions to noncontrolling partners in the Partnership (11,766) (44,449) (52,072)
Net Proceeds from sale of Partnership units 0 60,291 0
Proceeds from stock options exercised 264 992 0
Proceeds from stock issued under our employee stock purchase plan 803 356 0
Purchases of treasury stock (1,759) (2,788) (1,515)
Contribution from Exterran Corporation 18,744 44,720 49,176
Net cash provided by (used in) financing activities 54,050 (19,775) (183,285)
Net increase (decrease) in cash and cash equivalents (4,926) 7,402 1,571
Cash and cash equivalents at beginning of period 10,536 3,134 1,563
Cash and cash equivalents at end of period 5,610 10,536 3,134
Supplemental disclosure of cash flow information:      
Interest paid, net of capitalized amounts 86,758 78,891 77,958
Income taxes refunded, net (2,131) (695) (3,991)
Supplemental disclosure of non-cash transactions:      
Accrued capital expenditures 17,491 22,490 6,274
Non-cash consideration in March 2016 Acquisition 0 0 3,165
Partnership units issued in March 2016 Acquisition 0 0 1,799
Issuance of Archrock common stock pursuant to Merger, net of tax $ 57,421 $ 0 $ 0